Press Releases Leap Therapeutics, Inc.

Equities

LPTX

US52187K2006

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-20 EDT			5-day change	1st Jan Change
1.96 ^USD	+1.03%		-10.91%	-52.71%

05-14	HC Wainwright Adjusts Price Target on Leap Therapeutics to $5.50 From $7, Maintains Buy Rating	MT
05-13	Leap Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Leap Therapeutics Announces $40 Million Private Placement	04-11	PR
Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference	01-03	PR
Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients	01-02	PR
Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium	12-12	AQ
Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference	11-21	PR
Leap Therapeutics Reports Third Quarter 2023 Financial Results	11-13	PR
Leap Therapeutics to Participate at Upcoming Investor Conferences	23-09-05	PR
Leap Therapeutics Reports Second Quarter 2023 Financial Results	23-08-15	AQ
Leap Therapeutics Announces Initiation of Randomized Controlled Part B of the DeFianCe Study of DKN-01 in Colorectal Cancer Patients	23-07-12	PR
Leap Therapeutics Announces Reverse Stock Split	23-06-20	PR
Leap Therapeutics Reports First Quarter 2023 Financial Results	23-05-16	AQ
Leap Therapeutics : Reports First Quarter 2023 Financial Results - Form 8-K	23-05-15	PU
LEAP THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	23-04-26	AQ
Leap Therapeutics : Announces Completion of Enrollment in Part A of the DeFianCe Study of - Form 8-K	23-04-12	PU
LEAP THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	23-04-12	AQ
Leap Therapeutics Announces Completion of Enrollment in Part A of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients	23-04-12	PR
LEAP THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-04-07	AQ
Leap Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results	23-03-27	AQ
LEAP THERAPEUTICS, INC. Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits (form 8-K/A)	23-03-24	AQ
LEAP THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-03-24	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Leap Therapeutics, Inc.

Equities

LPTX

US52187K2006

Press Releases

Filters